The Next Generation Biotech Media
SalioGen Therapeutics, a Burlington-based biotech startup, announced on March 1st that it had closed its $20 million Series A financing round. The funds will support preclinical validation of mammal-derived enzyme …
Read More
On February 24th, ICON plc, a Dublin-based CRO, announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. Under the terms, the acquisition will be in …
Read More
After remaining in stealth mode in the past year, Jaguar Gene Therapy and its ciliopathy-focused subsidiary Axovia Therapeutics has launched itself with a Series A to develop adeno-associated virus serotype …
Read More
Roivant Sciences, a healthcare company focused on applying technology to drug developments, has struck a deal with Silicon Therapeutics that will help bring the latter under the VantAI drug discovery …
Read More
On February 23, Munich-based SIRION Biotech GmbH announced signing a license and collaboration agreement with Sanofi. The agreement intends to harness SIRION’s capabilities as a leader in viral vector-based gene …
Read More
February 27th, 2021 – Just a day after the FDA advisory panel’s unanimous recommendation, the US Food and Drug Administration (USFDA) has issued an emergency use authorization (EUA) for Johnson …
Read More
On February 23rd, Chengdu-based Clover Biopharmaceuticals announced the completion of an oversubscribed Series C funding round of $230 million. The funds will be directed mainly for the pipeline expansion on …
Read More
February 26th, 2021 – Johnson & Johnson has received endorsement from the Vaccines and Related Biological Products Advisory Committee (VRBPAC) for its single-shot COVID-19 vaccine, Ad26.COV2.S. The panel that convened …
Read More
Orna Therapeutics, a Cambridge-based biotech company, announced on February 24th that they have managed to close their $80 million Series A financing round. The start-up originating out of Massachusetts Institute …
Read More
Pandion’s short run as independent biotech is coming to an end. Almost two years after coming out of stealth mode, Merck and Co. is acquiring the company for its impressive …
Read More